Chronic & Debilitating Diseases

Chronic & Debilitating Diseases April 13, 2022

World Parkinson’s Day 2022: Where We Are Now

Parkinson’s Disease is the fastest growing neurological condition. Fundamental knowledge about the disease is lacking, while treatment still revolves around 60-year old dopamine replacement therapy.

Chronic & Debilitating Diseases December 8, 2021

The Obesity Epidemic: Pharmaceutical Responses?

The growing obesity epidemic is a call to action by pharma and society are large; what are the responses?

Chronic & Debilitating Diseases November 18, 2021

Novel Treatments in Alzheimer’s Disease

With still no definitive treatment for Alzheimer’s Disease, new treatment candidates on the horizon look promising.

Chronic & Debilitating Diseases June 2, 2021

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June the FDA may approve Biogen Alzheimer’s drug, Aducanumab, which aims to slow the disease. But data concerns and FDA ‘closeness’ spell trouble.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings

Precision in Three Dimensions: A Novel Approach to Tumor Resection and Reconstruction of the Femoral Trochanter

Blueprint for the Future: Establishing Rigorous Standards for Medical AI Data

Halides in Focus: A Fluorometric Leap for Clinical Diagnostics

Chronic & Debilitating Diseases

World Parkinson’s Day 2022: Where We Are Now

The Obesity Epidemic: Pharmaceutical Responses?

Novel Treatments in Alzheimer’s Disease

First Potential Alzheimer’s Drug on the Brink of FDA Approval